Skip to main content
Premium Trial:

Request an Annual Quote

NuGen Raises $7.5M in Series C

NEW YORK, Aug. 20 (GenomeWeb News) - NuGen Technologies of San Carlos, Calif., has raised $7.5 million in a Series C financing round, the company said Tuesday.


The financing round was led by individual investors, including William Rutter, co-founder of Chiron; George Rathmann, founder of Amgen and former CEO of Hyseq; and James Wilson, former president of Syntex, Neurex and LifeScan. Sutter Hill Ventures, of Palo Alto, Calif, as well as current investors Radius Venture Partners, The Band of Angels Fund, and MedCapital Ventures.


As a result of the financing, Rutter will join the company's board of directors.


The company , which makes nucleic acid and protein amplification and detection systems, said the proceeds of the financing would be used to further develop its infrastructure and its products.

The Scan

Omicron's Emergence

The World Health Organization has called Omicron a SARS-CoV-2 "variant of concern," the Los Angeles Times writes.

Not as Much

Merck's pill to treat COVID-19 reduces the risk of hospitalization and death among COVID-19 patients by less than previously reported, the New York Times says.

Bats That Hang Together

Discover magazine writes that researchers have found a social microbiome among vampire bats.

PLOS Papers on CEWAS, Simian Varicella Virus Transcriptome, Dermatomyositis Markers

In PLOS this week: multi-omic approach to home in on genetic risk variants, transcriptomic analysis of the simian varicella virus, and more.